Form 4: Boston Scientific EVP John Bradley Sorenson Executes Stock Option and Sells Shares Under 10b5-1 Plan

John Bradley Sorenson, EVP of Global Operations at Boston Scientific, exercised stock options and sold shares of common stock under a pre-established Rule 10b5-1 trading plan.

Summary

• On April 1, 2024, John Bradley Sorenson, EVP of Global Operations at Boston Scientific, exercised stock options to acquire 16,351 shares of common stock at a price of $16.31 per share.
• Simultaneously, Sorenson sold 16,351 shares of Boston Scientific common stock at a weighted average price of $69.2966 per share, with individual sales ranging from $68.10 to $68.53.
• These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 6, 2023.
• Following these transactions, Sorenson directly owns 50,638 shares of Boston Scientific common stock.

Sentiment

Score: 5

Explanation: The document simply reports stock transactions by an executive, which is a neutral event. The use of a 10b5-1 plan suggests proper governance.

Industry Context

Executive stock transactions are common and are often conducted under pre-arranged trading plans like Rule 10b5-1 to avoid accusations of insider trading. These plans allow insiders to sell shares at predetermined times and prices.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a form of long-term incentive.
• Rule 10b5-1 plans are a standard practice among corporate executives to manage their stock holdings and avoid potential conflicts of interest.
• Comparing Sorenson's transactions to those of executives at similar medical device companies (e.g., Medtronic, Abbott) would provide further context on the scale and frequency of such activities.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small volume of shares traded.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates